IGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63 Receives Award
IGC Pharma, Inc (NYSE American: IGC) ("IGC" or the "Company"), today announced that its Advisor, Professor T. Govindaraju the inventor of the investigational Alzheimer’s drug candidate, TGR-63, received the Government of India-instituted National Technology Award (Translational Research) for “Outstanding Contribution in Commercializing Innovative Indigenous Technologies” from the Minister of State for Science and Technology and Earth Sciences.
- IGC Pharma, Inc (NYSE American: IGC) ("IGC" or the "Company"), today announced that its Advisor, Professor T. Govindaraju the inventor of the investigational Alzheimer’s drug candidate, TGR-63, received the Government of India-instituted National Technology Award (Translational Research) for “Outstanding Contribution in Commercializing Innovative Indigenous Technologies” from the Minister of State for Science and Technology and Earth Sciences.
- IGC Pharma, Inc., acquired exclusive rights to TGR-63 from researchers at India-based Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) that created the TGR-63 molecule.
- Pre-clinical testing demonstrates that TGR-63 holds the potential to ameliorate amyloid plaque a key hallmark of Alzheimer’s disease.
- The Department of Science and Technology (DST)-Technology Development Board (TDB), Government of India recognized Professor Govindaraju with the prestigious award on May 14, 2023.